Rosiglitazone Intervention Study in Patients With Type 1.5 Diabetes.

Trial Profile

Rosiglitazone Intervention Study in Patients With Type 1.5 Diabetes.

Completed
Phase of Trial: Phase III

Latest Information Update: 01 Feb 2013

At a glance

  • Drugs Rosiglitazone (Primary) ; Glibenclamide
  • Indications Type 2 diabetes mellitus
  • Focus Pharmacodynamics
  • Most Recent Events

    • 07 Jun 2017 Biomarkers information updated
    • 13 Jul 2011 Official Title amended as reported by ClinicalTrials.gov.
    • 14 Apr 2009 Actual end date (Dec 2008), actual patient number (65), additional lead centres added as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top